Neuromuscular blocking agents: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Sources==" to "==References==") |
No edit summary |
||
| Line 38: | Line 38: | ||
| | | | ||
*[[tachycardia]] (slight) | *[[tachycardia]] (slight) | ||
*(no hypotension) | *(no [[hypotension]]) | ||
|- | |- | ||
|} | |} | ||
==See Also== | |||
*Reversal agent: [[Sugammadex]] | |||
==References== | ==References== | ||
Revision as of 03:22, 5 January 2017
Background
- Non-depolarizing
- Competitively block binding of ACh to its receptors
- Depolarizing
- Depolarizing skeletal muscle fiber
- Persistent depolarization makes the muscle fiber resistant to further stimulation by ACh
Types
| Agent | Time to onset (seconds) | Duration (minutes) | Side effects |
|---|---|---|---|
| Non-Depolarizing | |||
| Succinylcholine | fasciculations, post-operative pain | ||
| Depolarizing | |||
| Vecuronium (Norcuron) | 60 | 30–40 | Few, may cause prolonged paralysis and promote muscarinic block |
| Rocuronium (Zemuron) | 75 | 45–70 | may promote muscarinic block |
| Pancuronium (Pavulon) | 90 | 180 or more |
|
See Also
- Reversal agent: Sugammadex